Metraipolis › archive › dc_9045ec5a0ef4
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis — Europe PMC PMID:41041167
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41041167
- DOI
- 10.1186/s44356-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:37:55.896Z
- SHA-256 of the archived text
e8c091df3401aa58fd606a7a626ec1734a5d8cdd1e25954109272ef4310452a3- Stable URL of this page
https://metraipolis.com/documento/dc_9045ec5a0ef4
How to cite
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis — Europe PMC PMID:41041167 — Europe PMC (en), https://europepmc.org/article/MED/41041167 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9045ec5a0ef4 (Metraipolis archive dc_9045ec5a0ef4, sha256 e8c091df3401aa58fd606a7a626ec1734a5d8cdd1e25954109272ef4310452a3)
BibTeX
@misc{dc9045ec5a0ef4,
title = {Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasis — Europe PMC PMID:41041167},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41041167},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9045ec5a0ef4; sha256 e8c091df3401aa58fd606a7a626ec1734a5d8cdd1e25954109272ef4310452a3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41041167. Agents can read the archived copy with the MCP tool read_document.